Falls are a leading cause of injury and death in older adults, and pharmacists are in a key position to help prevent them. This episode highlights how to identify medication risks, share practical prevention strategies, and connect patients with trusted tools and resources. Tune in to learn how you can make a meaningful impact in reducing falls in your community. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Kristin Meyer PharmD, BCGP, FASCP
Professor of Pharmacy Practice
Drake University College of Pharmacy and Health Sciences

Joshua Davis Kinsey and Kristin Meyer have no relevant financial relationships to disclose. 

RESOURCES

• National Council on Aging (NCOA) Falls Prevention
• NCOA Falls Prevention Awareness Week
• NCOA Falls Free CheckUp®
• CDC STEADI

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common medication classes and household hazards associated with increased fall risk in older adults.
2. Describe the pharmacist's role in fall prevention through medication review, patient education, and community engagement.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-269-H05-P
Initial release date: 9/8/2025
Expiration date: 9/8/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

With shifting policies, payment models, and an unpredictable respiratory virus landscape,  pharmacy teams need more than clinical updates to prepare for the upcoming immunization season. This episode explores key issues shaping immunization practice today — including policy changes, billing and documentation trends, and how teams can proactively adapt and advocate for their role. Tune in for timely insights that go beyond the clinical headlines and complement our in-depth, on-demand course, Annual Immunization Update 2025. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmD
Professor
North Dakota State University 

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize recent policy and reimbursement updates that influence pharmacy-based immunization services and their potential to improve patient access to care.
2. Identify strategies pharmacy teams can use to prepare for the 2025-26 respiratory virus season in ways that support timely, equitable, and effective patient immunization.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-286-H01-P
Initial release date: 9/1/2025
Expiration date: 9/1/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Low-dose naltrexone (LDN) is generating growing interest as a potential therapy for conditions such as chronic pain and immune-related disorders. This episode offers a foundational overview of what LDN is, how it’s thought to work, where current evidence stands, and how pharmacists may encounter it in practice. Learn what pharmacists need to know to confidently approach patient questions about LDN and how it fits into current conversations in pharmacy and patient care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Michelle Moser, RPh
Retired Compounding Pharmacist

Joshua Davis Kinsey has no relevant financial relationships to disclose.

Michelle Moser was a volunteer board member for LDN Research Trust (ended June 2025), a board member for Alliance for Pharmacy Compounding (ended September 2024), and an employee of Revelation Pharma (ended June 2024). All relevant financial relationships have been mitigated.   

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define low-dose naltrexone (LDN) and describe how it differs from traditional naltrexone dosing.   
2. Identify proposed mechanisms of action and areas of emerging interest related to LDN use in practice.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-275-H01-P
Initial release date: 8/25/2025
Expiration date: 8/25/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Compounded medications serve a critical role in meeting patient-specific needs, but compliance is essential to ensure safety and quality. This episode covers what pharmacists need to know about documentation, prescription validity, beyond-use dating, and common missteps that can put compliance at risk. Tune in to strengthen your compounding practices and stay aligned with current regulatory expectations.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Jessica Gustin, PharmD
CMO & PIC/COO
Gwinnett Drugs/SynerGrx

Joshua Davis Kinsey and Jessica Gustin have no relevant financial relationships to disclose.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify key compliance requirements related to patient-specific prescriptions and compounded medication preparation.
2. Describe common compliance challenges in pharmacy compounding and strategies to avoid regulatory missteps.

0.05 CEU/0.5 Hr
UAN:  0107-0000-25-273-H07-P
Initial release date: August 18, 2025
Expiration date: August 18, 2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Uncontrolled hypertension continues to drive cardiovascular risk and remains a major gap in chronic disease management. This episode discusses what pharmacists need to know to support treatment adherence, identify therapeutic gaps, and address barriers to blood pressure control. Listen to strengthen your role in helping patients achieve meaningful, sustained outcomes. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Ryan Jacobsen, PharmD, BCPS
Clinical Pharmacy Specialist
U of Iowa HealthCare

Joshua Davis Kinsey and Ryan Jacobsen have no relevant financial relationships to disclose. 

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify common causes and consequences of uncontrolled hypertension in various patient populations.
2. Describe the pharmacist's role in recognizing gaps in therapy, addressing adherence, and supporting blood pressure control.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-271-H01-P
Initial release date: 8/11/2025
Expiration date: 8/11/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

With sexually transmitted infection (STI) rates continuing to rise, over-the-counter testing kits are expanding access to care, and pharmacists are well-positioned to support their safe and effective use. This episode explores key facts about available OTC kits, regulatory updates, counseling responsibilities, and the potential for test-and-treat models in pharmacy practice. Join us to learn how pharmacists can contribute meaningfully to STI prevention and care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Elizabeth Skoy, PharmD
Professor
North Dakota State University

Joshua Davis Kinsey and Elizabeth Skoy have no relevant financial relationships to disclose.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify the types and regulatory status of over-the-counter STI testing kits available to patients.
2. Describe the pharmacist's role in educating patients on the use of OTC STI kits and recognizing potential opportunities to support follow-up care or treatment.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-270-H01-P
Initial release date: 8/4/2025
Expiration date: 8/4/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Pharmacists are key partners in helping patients navigate the challenges of managing pain safely and effectively. This episode covers practical strategies for counseling, identifying potential concerns in therapy, and supporting appropriate treatment, plus a quick review of the newly approved non-opioid option. Tune in to strengthen your clinical confidence and improve outcomes in pain care. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Lorin Fisher PharmD, BCACP
Residency Program Director
University of Iowa

Joshua Davis Kinsey and Lorin Fisher have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Recognize essential counseling points and patterns in medication use that pharmacists should address when managing patients with pain.
2. Describe the role of pharmacists in supporting safe and effective pain management, including awareness of newly approved medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-258-H08-P
Initial release date: 7/28/2025
Expiration date: 7/28/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

HIV treatment has evolved significantly, offering streamlined regimens and improved patient outcomes. This episode will discuss the latest antiretroviral therapy (ART) guidelines, highlighting preferred regimens, key pharmacologic considerations, and practical counseling strategies for pharmacists. Tune in to enhance your clinical knowledge and play a pivotal role in optimizing care for individuals living with HIV. 

Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

Rachel Maynard, PharmD
Lead Editor
Pyrls

Joshua Davis Kinsey and Rachel Maynard have no relevant financial relationships to disclose. 

BONUS: With this episode, you also get exclusive, FREE access to beautifully designed clinical charts and practice resources from our friends at Pyrls, that you can use in your everyday practice. Click the links below to access these practical tools:

• HIV Pharmacotherapy
• HIV Medications
• And more!

 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Identify current guideline-recommended antiretroviral therapy (ART) regimens and their key components.
2. Describe important counseling points for pharmacists supporting patients on HIV treatment, including adherence, side effects, and drug interactions.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-245-H02-P
Initial release date: 7/21/2025
Expiration date: 7/21/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Integrative oncology blends conventional cancer treatments with supportive therapies like nutrition, acupuncture, and mind-body practices to improve patient outcomes and quality of life. This episode outlines what pharmacists need to know about the principles of integrative medicine, how to evaluate evidence-based resources, and counseling tips for guiding patients through safe, effective complementary options. Tune in to strengthen your ability to support cancer patients with credible, compassionate, and comprehensive care. 

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Ginger Blackmon, PharmD
Associate Director of Clinical Initiatives 
NCODA

Joshua Davis Kinsey and Ginger Blackmon have no relevant financial relationships to disclose.

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define integrative oncology and identify its role in supporting patients undergoing conventional cancer treatment.
2. Describe how pharmacists can evaluate and counsel on evidence-based complementary therapies used in integrative oncology.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-257-H01-P
Initial release date: 7/14/2025
Expiration date: 7/14/2026
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram

Integrative oncology blends conventional cancer treatments with supportive therapies like nutrition, acupuncture, and mind-body practices to improve patient outcomes and quality of life. This episode outlines what pharmacists need to know about the principles of integrative medicine, how to evaluate evidence-based resources, and counseling tips for guiding patients through safe, effective complementary options. Tune in to strengthen your ability to support cancer patients with credible, compassionate, and comprehensive care.

HOST
Joshua Davis Kinsey, PharmD
VP, Education
CEimpact

GUEST
Ginger Blackmon,PharmD
Associate Director of Clinical Initiatives 
NCODA

Joshua Davis Kinsey and Ginger Blackmon have no relevant financial relationships to disclose.
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define integrative oncology and identify its role in supporting patients undergoing conventional cancer treatment.
2. Describe how pharmacists can evaluate and counsel on evidence-based complementary therapies used in integrative oncology.

0.05 CEU/0.5 Hr
UAN: 0107-0000-25-256-H01-P
Initial release date: 7/7/2025
Expiration date: 7/7/2028
Additional CPE details can be found here.

Follow CEimpact on Social Media:
LinkedIn
Instagram